These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 33301014)
41. Pooling samples: a testing option for SARS-CoV-2 during a supply shortage. Salimnia H; Mitchell R; Gundel A; Cambell A; Gammou F; Chopra T; Fairfax M Diagn Microbiol Infect Dis; 2021 Jan; 99(1):115205. PubMed ID: 33190092 [TBL] [Abstract][Full Text] [Related]
42. The Missing Piece - SARS-CoV-2 Testing and School Reopening. Rafiei Y; Mello MM N Engl J Med; 2020 Dec; 383(23):e126. PubMed ID: 33085856 [No Abstract] [Full Text] [Related]
43. Universal screening for novel coronavirus disease 2019 (COVID-19) for asymptomatic parturients: May not be beneficial at this time. Henderson CE; Rezai S; Jackman JM J Med Virol; 2021 Mar; 93(3):1198-1200. PubMed ID: 32915477 [No Abstract] [Full Text] [Related]
53. Role of presymptomatic transmission of COVID-19: evidence from Beijing, China. Zhang Y; Muscatello D; Tian Y; Chen Y; Li S; Duan W; Ma C; Sun Y; Wu S; Ge L; Yang P; Jia L; Wang Q; MacIntyre CR J Epidemiol Community Health; 2021 Jan; 75(1):84-87. PubMed ID: 32855261 [TBL] [Abstract][Full Text] [Related]
54. DNA Cross-Reactivity of the CDC-Specified SARS-CoV-2 Specimen Control Leads to Potential for False Negatives and Underreporting of Viral Infection. Rosebrock AP Clin Chem; 2021 Jan; 67(2):435-437. PubMed ID: 33313692 [No Abstract] [Full Text] [Related]
55. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China. Wu X; Fu B; Chen L; Feng Y J Med Virol; 2020 Oct; 92(10):1795-1796. PubMed ID: 32311142 [No Abstract] [Full Text] [Related]
56. Universal masking is an effective strategy to flatten the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) healthcare worker epidemiologic curve. Seidelman JL; Lewis SS; Advani SD; Akinboyo IC; Epling C; Case M; Said K; Yancey W; Stiegel M; Schwartz A; Stout J; Sexton DJ; Smith BA Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1466-1467. PubMed ID: 32576336 [No Abstract] [Full Text] [Related]
57. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
58. Mass population screening for SARS-CoV-2 and false positives-why Liverpool shows we have a problem. Cook D BMJ; 2020 Dec; 371():m4954. PubMed ID: 33384318 [No Abstract] [Full Text] [Related]
59. Just 2% of SARS-CoV-2-positive individuals carry 90% of the virus circulating in communities. Yang Q; Saldi TK; Gonzales PK; Lasda E; Decker CJ; Tat KL; Fink MR; Hager CR; Davis JC; Ozeroff CD; Muhlrad D; Clark SK; Fattor WT; Meyerson NR; Paige CL; Gilchrist AR; Barbachano-Guerrero A; Worden-Sapper ER; Wu SS; Brisson GR; McQueen MB; Dowell RD; Leinwand L; Parker R; Sawyer SL Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 33972412 [TBL] [Abstract][Full Text] [Related]
60. Response of Clinical Laboratories to the Ongoing COVID-19 Pandemic. Kim YJ; Sung H; Ki CS; Hur M Ann Lab Med; 2021 Nov; 41(6):519-520. PubMed ID: 34108278 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]